How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Por Sawka, A M, Straus, S, Gafni, A, Brierley, J D, Tsang, R W, Rotstein, L, Ezzat, S, Thabane, L, Rodin, G, Meiyappan, S, David, D, Goldstein, D P
Publicado em 2011

Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study

Por Sawka, A. M., Straus, S., Gafni, A., Meiyappan, S., David, D., Rodin, G., Brierley, J. D., Tsang, R. W., Thabane, L., Rotstein, L., Ezzat, S., Goldstein, D. P.
Publicado em 2011

Risk factors for low BMD in healthy men age 50 years or older: a systematic review

Por Papaioannou, A., Kennedy, C. C., Cranney, A., Hawker, G., Brown, J. P., Kaiser, S. M., Leslie, W. D., O’Brien, C. J. M., Sawka, A. M., Khan, A., Siminoski, K., Tarulli, G., Webster, D., McGowan, J., Adachi, J. D.
Publicado no Osteoporos Int (2008)

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

Por Papaioannou, A., Kennedy, C. C., Ioannidis, G., Gao, Y., Sawka, A. M., Goltzman, D., Tenenhouse, A., Pickard, L., Olszynski, W. P., Davison, K. S., Kaiser, S., Josse, R. G., Kreiger, N., Hanley, D. A., Prior, J. C., Brown, J. P., Anastassiades, T., Adachi, J. D.
Publicado no Osteoporos Int (2007)